KING, B.; SOUNG, J.; TZIOTZIOS, C.; RUDNICKA, L.; JOLY, P.; GOODERHAM, M.; SINCLAIR, R.; ANWAY, S.; WAJSBROT, D.; LEJEUNE, A. .; ZWILLICH, S. Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s291, 2023. DOI: 10.25251/skin.7.supp.291. Disponível em: https://jofskin.org/index.php/skin/article/view/2417. Acesso em: 3 jul. 2024.